Incidence and clinical impact of fluoroquinolone-resistant Escherichia coli in the faecal flora of cancer patients treated with high dose chemotherapy and ciprofloxacin prophylaxis-Reference-Cited by-同舟云学术

Incidence and clinical impact of fluoroquinolone-resistant Escherichia coli in the faecal flora of cancer patients treated with high dose chemotherapy and ciprofloxacin prophylaxis

Published:1999-07 Issue:1 Volume:44 Page:117-120
ISSN:1460-2091
Container-title:Journal of Antimicrobial Chemotherapy
language:en
Short-container-title:

Author:

Perea Sofia,Hidalgo Manuel,Arcediano Alberto,Ramos Maria Jose,Gomez Carlos,Hornedo Javier,Lumbreras Carlos,Folgueira Dolores,Cortes-Funes Hernan,Rodriguez-Noriega Antonio

Publisher

Oxford University Press (OUP)

Subject

Infectious Diseases,Pharmacology (medical),Pharmacology,Microbiology (medical)

Link

http://academic.oup.com/jac/article-pdf/44/1/117/13056757/JAC441117.pdf

Reference10 articles.

1. Gratwohl, A., Hermans, J. & Baldomero, H. (1997). Blood and marrow transplantation activity in Europe in 1995. European Group for Blood and Marrow Transplantation. Bone Marrow Transplantation19, 407–19.

2. Schmitz, N., Linch, D. C., Dreger, P., Goldstone, A. H., Boogaerts, M. A., Ferrant, A. et al. (1996). Randomized trial of filgastrim-mobilised peripheral blood progenitor cell transplantation versus autologous bone-marrow transplantation in lymphoma patients. Lancet347, 353–7.

3. Momin, F. & Chandrasekar, P. H. (1995). Antimicrobial prophylaxis in bone marrow transplantation. Annals of Internal Medicine123, 205–15.

4. Carratala, J., Fernandez-Sevilla, A., Tubau, F., Callis, M., Gudiol, F. & Ball, P. (1995). Emergence of quinolone-resistant Escherichia coli bacteremia in neutropenic patients with cancer who have received prophylactic norfloxacin. Clinical Infectious Diseases20, 557–63.

5. Carratala, J., Fernandez-Sevilla, A., Tubau, F., Dominguez, M. A. & Gudiol, F. (1996). Emergence of fluorquinolone-resistant Escherichia coli in fecal flora of cancer patients receiving norfloxacin prophylaxis. Antimicrobial Agents and Chemotherapy40, 503–5.

Cited by 25 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Incomplete recovery of the fecal flora of hematological patients with neutropenia and repeated fluoroquinolone prophylaxis;Infection and Drug Resistance;2017-06

2. Ciprofloxacin prophylaxis delays initiation of broad-spectrum antibiotic therapy and reduces the overall use of antimicrobial agents during induction therapy for acute leukaemia: A single-centre study;Infectious Diseases;2016-02-25

3. Clinical Impact of Fluoroquinolone-Resistant Escherichia coli in the Fecal Flora of Hematological Patients with Neutropenia and Levofloxacin Prophylaxis;PLoS ONE;2014-01-22

4. Relapsing bloodstream infections during treatment of acute leukemia;Annals of Hematology;2013-11-28

5. Impact of Antibiotic Use during Hospitalization on the Development of Gastrointestinal Colonization with Escherichia coli with Reduced Fluoroquinolone Susceptibility;Infection Control & Hospital Epidemiology;2013-10